Clinical Trial Update: Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating delpazolid as add-on therapy for refractory Mycobacterium abscessus complex infections; the study is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Infection
• Nontuberculous Mycobacterial Infection

Drugs mentioned

• delpazolid (delpazolid)

Snippet

Sponsor: LigaChem Biosciences, Inc. | Conditions: Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection | Phase 2 | Status: ACTIVE_NOT_RECRUITING